Evidence map›Paper›PMID 37630188›Full record

ReviewMolecules (Basel, Switzerland)2023

Machine Learning Techniques Applied to the Study of Drug Transporters.

Xiaorui Kong, Kexin Lin, Gaolei Wu, Xufeng Tao, Xiaohan Zhai, Linlin Lv, Deshi Dong, Yanna Zhu, Shilei Yang

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaorui KongDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.ORCID 0009-0004-2544-4932
Kexin LinDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Gaolei WuDepartment of Pharmacy, Dalian Women and Children's Medical Group, Dalian 116024, China.
Xufeng TaoDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Xiaohan ZhaiDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Linlin LvDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Deshi DongDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Yanna ZhuDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.ORCID 0000-0003-2589-2423
Shilei YangDepartment of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Dalian Medical University · CNDalian Maternal and Child Health Hospital · CN

Funding

National Natural Science Foundation of China Grant/Award Number: 82003837
6 · The paper itself

Abstract

With the advancement of computer technology, machine learning-based artificial intelligence technology has been increasingly integrated and applied in the fields of medicine, biology, and pharmacy, thereby facilitating their development. Transporters have important roles in influencing drug resistance, drug-drug interactions, and tissue-specific drug targeting. The investigation of drug transporter substrates and inhibitors is a crucial aspect of pharmaceutical development. However, long duration and high expenses pose significant challenges in the investigation of drug transporters. In this review, we discuss the present situation and challenges encountered in applying machine learning techniques to investigate drug transporters. The transporters involved include ABC transporters (P-gp, BCRP, MRPs, and BSEP) and SLC transporters (OAT, OATP, OCT, MATE1,2-K, and NET). The aim is to offer a point of reference for and assistance with the progression of drug transporter research, as well as the advancement of more efficient computer technology. Machine learning methods are valuable and attractive for helping with the study of drug transporter substrates and inhibitors, but continuous efforts are still needed to develop more accurate and reliable predictive models and to apply them in the screening process of drug development to improve efficiency and success rates.

Indexed as

Artificial IntelligenceNeoplasm ProteinsATP Binding Cassette Transporter, Subfamily G, Member 2Machine LearningMembrane Transport ProteinsATP Binding Cassette Transporter, Subfamily G, Member 2Membrane Transport ProteinsNeoplasm Proteinsdrug transportersinhibitermachine learningsubstrate

Identifiers

PMID37630188
PMCPMC10459831
OpenAlexW4385647760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.